BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

10 articles for K Yoshino

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis and antiinflammatory activity of some 2-(substituted-pyridinyl)benzimidazoles.EBI
TBA
New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.EBI
Nippon Organon K.K.
Studies on selectin blocker. 1. Structure-activity relationships of sialyl Lewis X analogs.EBI
Institute of Cancer Research
Studies on selectin blockers. 2. Novel selectin blocker as potential therapeutics for inflammatory disorders.EBI
New Drug Research Laboratory
Azasugar-based MMP/ADAM inhibitors as antipsoriatic agents.EBI
Hokkaido Collaboration Center N-21
Synthesis and biological activity of selective azasugar-based TACE inhibitors.EBI
Organon K.K.
Design, synthesis and evaluation of novel azasugar-based MMP/ADAM inhibitors.EBI
Hokkaido Collaboration Center
Structure--activity relationships of azasugar-based MMP/ADAM inhibitors.EBI
Hokkaido Collaboration Center
Discovery of selective phosphonamide-based inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).EBI
Organon K.K.
New strategy for antedrug application: development of metalloproteinase inhibitors as antipsoriatic drugs.EBI
Organon K.K.